Collegium Pharmaceutical
COLL
eBay
EBAY
Halozyme Therapeutics
HALO
SilverCrest Metals
SILV
Workday
WDAY
US Stock MarketDetailed Quotes
ATDS DATA443 RISK MITIGATION INC
- 0.053
- 0.0000.00%
15min DelayClose Jan 7 16:00 ET
42.99KMarket Cap-0.01P/E (TTM)
0.000High0.000Low0Volume0.000Open0.053Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)806.62KShares7.00052wk High0.00P/B42.73KFloat Cap0.05052wk Low--Dividend TTM801.66KShs Float12.120Historical High--Div YieldTTM0.00%Amplitude0.050Historical Low--Avg Price1Lot Size
DATA443 RISK MITIGATION INC Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -28.89%245.23K | 293.59%355.97K | -40.72%213.3K | 162.44%782.1K | 127.00%261.31K | 304.05%344.87K | 32.25%-183.88K | 131.36%359.8K | -46.42%-1.25M | -5.95%-967.73K |
| Net income from continuing operations | 35.24%-1.28M | -1,787.29%-1.51M | -120.79%-1.63M | 56.30%-4.24M | 58.02%-1.62M | -25.08%-1.98M | 103.66%89.54K | 59.75%-737.89K | -50.01%-9.71M | -116.44%-3.85M |
| Operating gains losses | ---- | ---- | ---- | -8,572.40%-4.9M | --153.89K | ---153.89K | ---- | ---- | -86.49%57.88K | --0 |
| Depreciation and amortization | -69.16%75.64K | 725.02%122.66K | 87.71%471.89K | -36.08%631.54K | -29.81%120.06K | -11.22%245.23K | -94.66%14.87K | -4.19%251.39K | -11.32%987.99K | -39.20%171.05K |
| Other non cash items | -61.48%199.44K | 73.21%499.95K | 49.30%503.34K | -28.52%1.73M | 17.54%586.9K | 33.94%517.7K | -63.95%288.64K | -54.08%337.14K | -16.72%2.42M | -0.89%499.33K |
| Change In working capital | -43.71%922.85K | -73.48%1.03M | 71.54%678.09K | 66.96%6.59M | -70.82%684.1K | 338.43%1.64M | 1,749.90%3.88M | -61.32%395.3K | 4,269.38%3.95M | 13,266.73%2.34M |
| -Change in receivables | 52.66%-15.37K | 1,509.62%127.69K | 596.56%145.57K | -2,568.75%-277.79K | -186.19%-274.15K | 72.60%-32.48K | 166.33%7.93K | 110.56%20.9K | -113.26%-10.41K | 630.23%318.06K |
| -Change in prepaid assets | 115.67%58.75K | --0 | 68.77%-19.67K | 278.25%61.74K | 1,134.20%618.52K | -1,234.20%-374.83K | -1,370.07%-118.97K | -243.48%-62.99K | 51.08%-34.64K | 0.59%-59.81K |
| -Change in payables and accrued expense | -56.07%1.07M | -83.15%649.02K | 48.95%1.1M | 140.51%7.48M | -79.23%466.4K | 438.22%2.43M | 1,271.85%3.85M | 451.44%736.04K | 40,407.24%3.11M | 3,066.18%2.25M |
| -Change in other current liabilities | ---- | -16.11%90.99K | -145.98%-266.78K | ---- | ---- | ---- | --108.46K | ---108.46K | ---- | ---- |
| -Change in other working capital | 4.54%-362.14K | 500.38%160.1K | -45.81%-277.33K | -175.70%-669.58K | 20.44%-126.68K | -643.56%-379.37K | 138.84%26.67K | -118.24%-190.2K | 878.13%884.56K | -333.12%-159.23K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -28.31%247.23K | 292.50%353.97K | -40.72%213.3K | 162.44%782.1K | 127.00%261.31K | 304.05%344.87K | 32.25%-183.88K | 131.36%359.8K | -46.42%-1.25M | -5.95%-967.73K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 0 | -200.38%-1.69M | -11,292.30%-1.4M | 41.50%-118.1K | 2.68%-86.3K | 68.59%-81.13K | -305.64%-561.13K | -12.29K |
| Net PPE purchase and sale | --0 | --0 | --0 | 40.37%-185.52K | --0 | 91.04%-18.1K | 2.68%-86.3K | -879.78%-81.13K | -124.92%-311.13K | ---12.29K |
| Net business purchase and sale | ---- | ---- | ---- | -500.00%-1.5M | ---1.4M | ---- | ---- | ---- | ---250K | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | --0 | -200.38%-1.69M | -11,292.30%-1.4M | 41.50%-118.1K | 2.68%-86.3K | 68.59%-81.13K | -305.64%-561.13K | ---12.29K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -23.98%-294.81K | -275.83%-311.45K | -70.81%-292.81K | 61.54%986.28K | 61.86%1.22M | -139.64%-237.79K | -0.39%177.13K | 81.36%-171.43K | -71.47%610.56K | 1.62%752.75K |
| Net issuance payments of debt | 6.10%-251.47K | -2,318.39%-292.34K | -26.99%-267.49K | 232.57%756.91K | 49.14%1.25M | -7.21%-267.81K | -149.60%-12.09K | 45.06%-210.64K | -80.14%227.59K | 3.06%836.4K |
| Net common stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 9.94%931K | --102K |
| Net preferred stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -189.53%-412.73K | --0 |
| Net other financing activities | -186.64%-43.34K | -111.30%-19.12K | -164.57%-25.32K | 269.53%229.38K | 84.34%-29.07K | 141.88%50.02K | 10.27%169.22K | 131.68%39.21K | 56.89%-135.3K | -30.87%-185.65K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -23.98%-294.81K | -275.83%-311.45K | -70.81%-292.81K | 61.54%986.28K | 61.86%1.22M | -139.64%-237.79K | -0.39%177.13K | 81.36%-171.43K | -71.47%610.56K | 1.62%752.75K |
| Net cash flow | ||||||||||
| Beginning cash position | 199.17%47.58K | -95.35%5.06K | 4,839.84%84.57K | -99.86%1.71K | -97.86%4.89K | --15.9K | -40.22%108.96K | -99.86%1.71K | 1,949.80%1.2M | -83.38%228.99K |
| Current changes in cash | -332.00%-47.58K | 145.69%42.52K | -174.14%-79.51K | 106.90%83.04K | 135.14%79.86K | -104.81%-11.01K | 48.95%-93.05K | 110.49%107.24K | -204.98%-1.2M | -31.64%-227.27K |
| End cash Position | --0 | 199.17%47.58K | -95.35%5.06K | 4,850.35%84.75K | 4,850.35%84.75K | -97.86%4.89K | --15.9K | -40.22%108.96K | -99.86%1.71K | -99.86%1.71K |
| Free cash flow | -24.34%247.23K | 231.01%353.97K | -23.46%213.3K | 138.15%596.58K | 126.66%261.31K | 188.11%326.77K | 24.97%-270.18K | 89.27%278.67K | -57.34%-1.56M | -7.30%-980.02K |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |